Merck
HomeServicesContract ManufacturingViral Vector CTDMO Services

Viral Vector CTDMO Services

Our Viral Gene Therapy Offering

With 30+ years of gene therapy experience, we bring expertise in viral vector manufacturing and testing as well as a global organization to integrate regulatory, safety, and process development to fit your needs.

  • Pre-clinical through commercial manufacturing and testing services
  • Experience with Lentivirus, Adenovirus, AAV, and more
  • Customer-centric experts dedicated to your program’s success

Request Information


Processing Development

Leveraging our in-house expertise, we offer a complete range of process development (PD) services to improve yield and quality of your viral vectors.

Scientist working on gene therapy in laboratory

Gene Therapy Process Development

The breadth of our experience allows us to develop robust production processes to move your gene therapy products quickly through clinical trials and to commercialization.

Learn more about Gene Therapy Process Development


Manufacturing

Our viral and gene therapy manufacturing team has produced over 1,000 batches of virus, meeting rigorous timelines with a complete range of services, a state-of-the-art cGMP facility, and deep regulatory understanding.

Large Scale Gene Therapy Manufacturing

With over 30 years of viral vector manufacturing experience, we have charted multiple programs, clinical to commercial. Our experts will guide you through upstream and downstream development while keeping you from running aground on unexpected regulatory hurdles. With the launch of our large-scale CDMO facility, we’ll take you through the clinic and scale up to successfully bring your therapy to patients.

Learn more about Large Scale Gene Therapy Manufacturing



Related Resources